Paper Details

  1. Home
  2. Paper Details

Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.

Author: GerdthamU, JönssonL, KobeltG, KrieglsteinG K

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study examines the cost-effectiveness of different treatment strategies for glaucoma in Germany. The study focuses on patients newly diagnosed with primary open-angle glaucoma (POAG) or ocular hypertension (OH). Because the link between eye pressure (IOP) and blindness is not fully understood, the study measures the effectiveness of treatments based on their ability to control IOP over time. The study aims to assess the impact of new eye drops on the overall cost of glaucoma treatment.
Paper Details　
Original Abstract of the Article :
Economic evaluation of new treatments in the field of glaucoma represents a challenge. In the absence of a clear epidemiological link between intra-ocular pressure (IOP) and disease progression to blindness, the economic impact of treatments that lower IOP on long-term outcome cannot be estimated. A...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s004170050165

データ提供：米国国立医学図書館（NLM）

Glaucoma: Mapping the Costly Terrain

Glaucoma, a condition that can lead to blindness, is like a slow-moving sandstorm, gradually eroding vision over time. Managing this condition, like navigating a challenging desert, involves various treatment strategies, each with its own economic implications. This study sheds light on the financial costs associated with different glaucoma management approaches.

The researchers, armed with their economic tools, investigated treatment strategies for patients newly diagnosed with primary open-angle glaucoma (POAG) or ocular hypertension (OH) in Germany. Their focus was on the cost-effectiveness of different treatment options, particularly in the context of new topical therapies. Their findings offer a glimpse into the financial landscape of glaucoma management.

A Costly Desert of Vision Loss

The study revealed significant cost variations associated with different treatment approaches for glaucoma. This knowledge, like finding a new oasis of resources, can help optimize treatment strategies and potentially reduce the financial burden on patients and healthcare systems.

Navigating the Desert of Glaucoma

The economic insights provided by this study can inform patient decisions and healthcare planning for glaucoma management. It emphasizes the need to consider both the clinical effectiveness and the financial implications of different treatment options, helping individuals navigate the complex desert of glaucoma management.

Dr.Camel's Conclusion

The study serves as a valuable roadmap for navigating the financial aspects of glaucoma management. It emphasizes the importance of considering both clinical and economic factors when making treatment decisions, helping to ensure that patients can access the most effective and cost-effective care possible.

Date :
  1. Date Completed 1999-01-25
  2. Date Revised 2019-09-05
Further Info :

Pubmed ID

9825256

DOI: Digital Object Identifier

10.1007/s004170050165

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.